Aquarium Nanopore results need a clinical interpretation

Sequencing answers only part of the clinical question

A sequencing result can list microorganisms detected in a sample. The clinical question is more demanding: which organisms contribute to the observed problem, in which tissues, and with what supporting evidence? In a public aquarium, environmental information, clinical signs and lesions determine how a molecular signal should be interpreted.

A June 2026 report by Konrad Wojnarowski and colleagues in Pathogens describes four heterogeneous clinical submissions. One involved a sick pennant butterflyfish, Heniochus acuminatus, from a public aquarium; the others concerned farmed fish. Together they illustrate a possible diagnostic use of direct sequencing. They do not constitute a validation study in a representative aquarium population.

What the butterflyfish submission showed

The aquarium case comprised one submitted diagnostic sample containing organ swabs. Nanopore DNA sequencing produced a profile dominated by Streptococcus iniae, with other taxa also detected. A dominant organism can help direct an investigation, provided the result is considered alongside the fish’s condition and the origin of the sampled material.

Relative abundance describes a share of classified sequence reads. It is not the percentage of infected fish in the exhibit or a direct count of living bacteria in an organ. DNA extraction, the amount of host DNA and the references used to classify reads can influence the profile.

Where several organ swabs contribute to a submission, the result also cannot automatically assign an organism or a causal role to each organ separately. The laboratory and aquarium need an accurate description of what was sent before interpreting a list of identifications.

A broad approach with defined boundaries

Metagenomics examines genetic material without first requiring every organism to be isolated in culture. It can help orient an investigation involving several possible agents. This study focused principally on bacteria and on fungal or related organisms, including oomycetes in some of the submissions.

The output was not an exhaustive inventory of all infectious causes. The DNA-based workflow did not reliably assess RNA viruses, and dedicated viral and parasite analyses were outside the stated diagnostic scope. Their absence from the report should not be read as their exclusion from the case.

An analytical request should make that scope explicit. A targeted question and an exploratory screen serve different purposes. PCR can address a defined suspected agent, while histopathology can describe lesions and their distribution. Neither function becomes redundant because a broader sequencing result is available.

Limits that constrain the conclusions

The authors report that extraction blanks and no-template controls were not sequenced. Low-level contamination associated with reagents or handling therefore cannot be fully excluded, particularly in material with little microbial DNA. An uncommon taxon deserves more interpretation than its simple appearance in the results.

The submissions were few, came from different settings and involved different tissues. They cannot establish general clinical sensitivity, specificity or predictive values for aquarium collections. The underlying sequence data are reported as restricted, limiting independent reanalysis.

The paper also discusses speed and practical potential. It does not provide a standardised clinical comparison supporting a guaranteed turnaround time or cost for an aquarium. Those expectations need discussion with the laboratory before sampling, in relation to the actual question and available material.

A further limit concerns biological meaning. Detecting microbial DNA alone does not establish that the organism was alive, actively infecting tissue or responsible for disease. The signal could reflect infection, colonisation, environmental exposure or contamination. Its importance depends on how these possibilities fit the rest of the case.

Put the result beside lesions and history

A useful investigation combines sequencing with clinical observations, lesions and complementary testing. Water-system changes, recent introductions, animal movements and previous treatment can help explain the submission. These details do not prove causation, but they prevent interpretation of the sequence profile in isolation.

The tissue source is particularly important. A surface-associated microbial community and a result from an internal organ have different contexts, although neither automatically establishes disease. The report’s comparisons across tissues support attention to sampling strategy; they do not turn every identified organism into a confirmed pathogen in that individual.

Antimicrobial susceptibility testing answers another question again: how an isolate responds to antimicrobial agents under the test conditions. Sequencing-based identification alone is insufficient to choose treatment. Veterinary decisions need to account for the diagnostic evidence, the organism’s relevance, analytical options and the collection’s circumstances.

Prepare the submission around a decision

Before sending material, the team can identify the affected animals, describe the signs and clarify what the proposed test is expected to resolve. Individual samples and pooled submissions should remain distinguishable, with an explicit connection to the clinical record. This preparation helps interpretation regardless of the technology selected.

It is also useful to agree how an unexpected finding will be handled. The laboratory may recommend a confirmatory test or explain why a low-level detection cannot be given clinical weight. A result that generates a more focused question can still be useful; it need not provide an immediate final diagnosis to have value.

Direct sequencing therefore offers an additional source of evidence. The 2026 series documents one aquarium application while leaving substantial work to establish diagnostic performance and its place in a wider clinical pathway.

Vetofish’s analysis and diagnostic service can help prepare the case history and select complementary examinations with the aquarium and laboratory. For public aquarium teams, the aim is a reasoned connection between each result and the next health-management decision.